Lars Lindholm

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

Björn Dahlöf, Richard B. Devereux, Sverre E. Kjeldsen et al. · The Lancet · 2002 · 5.4K citations

Medicine, Cardiology, Internal Medicine +13

2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)

Guy De Backer, Anna F. Dominiczak, Renata Cífková et al. · European Heart Journal · 2006 · 2.4K citations · Full text

Medicine, Cardiology, Internal Medicine +16

Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial

Lennart Hansson, Lars Lindholm, Leo Niskanen et al. · The Lancet · 1999 · 2K citations

Medicine, Cardiology, Pharmacology +16

Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension)

Björn Dahlöf, L. Hansson, Lars Lindholm et al. · The Lancet · 1991 · 1.9K citations

Medicine, Cardiology, Geriatric Medicine +12

Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

Lars Lindholm, Hans Ibsen, Björn Dahlöf et al. · The Lancet · 2002 · 1.6K citations

Medicine, Cardiology, Internal Medicine +15